Disclosure of voting rights in connection with Annual General Meeting 2016

Oslo, 20 June 2016. In connection with the Annual General Meeting of Navamedic ASA, to be held today 20 June 2016, Chairman of the board of directors, Johan Reinsli, has received proxies to represent and vote for 2 232 137 shares which represents approximately  20,54 % of outstanding shares and voting rights in Navamedic ASA.

In addition, Johan Reinsli controls 244,400 shares, which represents approximately 2,25 % of outstanding shares and voting rights in Navamedic ASA, held by his wholly owned company Harding Invest AS.

Johan Reinsli currently represents a total of 2 476 537 shares which equals approximately 22,79 % of outstanding shares and voting rights in Navamedic ASA.

The powers of attorney are only valid at this Annual General Meeting and after its conclusion Johan Reinsli's shareholding in Navamedic ASA will represent approximately 2.25%.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.